This is an exciting time for the advancement in therapies designed specifically for Sjögren’s patients! Currently there are twelve companies in clinical trials with sixteen therapies that we hope will prove successful for Sjögren’s patients. However, patient participation is critical to ensure effective drugs can advance through the clinical trial process, and eventually come to market.
Each clinical trial has specific criteria for participating. So, when you call a site, they will ask you specific questions to see if you are eligible. Please know that calling a site is showing an interest in the trial (and not necessarily a commitment). So do call and demonstrate your interest! It is also important to demonstrate that there is demand for new therapeutics even if you choose not to participate after learning more.
If you are interested in learning more about clinical trials, please take a look at the information on our Clinical Trials page.